Viewing Study NCT04334759


Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-02-20 @ 7:25 PM
Study NCT ID: NCT04334759
Status: COMPLETED
Last Update Posted: 2025-07-18
First Post: 2020-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Sponsor: PrECOG, LLC.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module